thanks DBrent. I found the last 10 minutes most interesting. 1....

thanks DBrent. I found the last 10 minutes most interesting. 1. FDA approvals for ANDA's are down some 30% year on year, there was no mention of any FDA problems, and 2. That the FDA approval of at least 1- ANDA is imminent ( which in Company parlance 6 months) 3. Although cash reserves are reducing the Chairman nor the CEO have issued no concerns as to ACR's financial position. 4. Because licensing agreements are commercial in confidence, ACR gave a example of a company that did disclose its licensing deal as a 50/50 arrangement, The CEO then when on to say that this can be taken as a guide to the ACR partnership deals. Jet